The global empty capsules market is estimated to be worth $1,300 million in 2014 and grow at a 7 % CAGR during the forecast period of 2014 to 2019. This market is mainly driven by growing aging population; increasing therapeutic applications of capsules in pharmaceutical, nutraceutical, and cosmetics industries; and technological advancements in drug delivery formulations. The growing demand for alternative gelatin capsules such as Hydroxypropyl Methyl Cellulose (HPMC) capsules in the pharmaceutical and nutraceutical industries is driving the market during the forecast period.
Other growth drivers will be the demand for innovative drug delivery formulations in the pharmaceutical industry and increased consumption of dietary supplements. However, market growth is restricted by factors such as increasing gelatin prices, increasing demand for soft gelatin capsule formulations, and need for high capital expenditure from manufacturers to enter the empty capsules market.
In this report, the global empty capsules market is segmented by products, source of raw materials, therapeutic applications, and end users. The empty capsules products market is segmented into hard gelatin and nongelatin-based capsules. On the basis of source of raw materials, the market is segmented as pig-skin gelatin, bone-derived gelatin, bovine-hide gelatin, Hydroxypropyl Methyl Cellulose (HPMC), pullulan and starch materials, and others.
Based on therapeutic applications, the market is segmented as antibiotic drugs, vitamins and dietary supplements, antacid and antiflatulent preparations, anti-inflammatory drugs, cardiovascular therapy drugs, cough and cold preparations, antiemetic preparations, and others. The market is further segmented based on end users, which includes the pharmaceutical industry, nutraceutical industry, cosmetics industry, and research laboratories.
The total empty capsules market is further divided into four major geographies, namely, North America, Europe, Asia-Pacific, and Rest of the World (RoW). These regions are further analyzed at country level. The research report discusses key market drivers, restraints, and opportunities of the global market and its submarkets.
In 2013, the hard gelatin capsules segment accounted for the largest share of the global empty capsules market. The large share of this segment can be attributed to its wide application in pharmaceutical and nutraceutical industries to manufacture empty hard gelatin capsules. The hard gelatin capsules segment will continue to dominate this market by 2019, growing at a moderate CAGR during the forecast period.
North America represented the largest regional market for the global market in 2013, followed by Europe, Asia-Pacific, and RoW. North America and Europe are expected to witness a lower growth rate in the coming years as compared to the Asian market. The Asia-Pacific region represents the fastest-growing market for hard gelatin and nongelatin-based capsules. The high growth rate in the Asian market is primarily attributed to the increasing health awareness and growing affordability of healthcare services in this region.
The major players in the empty capsules market include ACG Worldwide (India), Capsugel (U.S.), CapsCanada Corporation (Canada), Qualicaps, Inc. (U.S.), Suheung Co., Ltd. (Korea), Medi-Caps Ltd. (India), Roxlor LLC (U.S.), Sunil Healthcare Ltd. (India), Snail Pharma Industry Co., Ltd. (China), and Bright Pharma Caps, Inc. (U.S.).
Source : Global News